ErbB2/HER2-specific NK Cells for Adoptive Cancer Immunotherapy

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Failed Adoptive Immunotherapy With Tumor-Specific T Cells

Cancer Research
Cancer ResearchOncology
2004English

Adoptive Immunotherapy of Cancer Using CD4+ T Cells

Current Opinion in Immunology
AllergyImmunology
2009English

Adoptive Cancer Immunotherapy With Human Vγ2vδ2 T Cells

English

Antigen-Specific Culture of Memory-Like CD8 T Cells for Adoptive Immunotherapy

Cancer immunology research
Cancer ResearchImmunology
2014English

Human Embryonic Stem Cell (hESC)-derived NK Cells for Cancer Immunotherapy

Science-Business eXchange
2009English

Application of Genetically Engineered Tumor-Specific Th1 Cells to Adoptive Tumor Immunotherapy

Annals of Cancer Research and Therapy
Cancer ResearchOncologyPharmacology
2004English

Septin Oligomerization Regulates Persistent Expression of ErbB2/HER2 in Gastric Cancer Cells

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2016English

Enhancing Adoptive Cancer Immunotherapy With Vγ2Vδ2 T Cells Through Pulse Zoledronate Stimulation

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy